Symetryx Corp 3/A
3/A · NeuBase Therapeutics, Inc. · Filed Sep 12, 2023
Insider Transaction Report
Form 3/AAmended
Symetryx Corp
10% Owner
Holdings
- 80,973
Common Stock, Par Value $0.0001 per Share
- 109,508
Common Stock, Par Value $0.0001 per Share
Footnotes (2)
- [F1]The shares listed in Table I, Row 1, Column 3 are beneficially owned by Barry Shiff, an individual through two retirement accounts. On the original Form 3 filed September 1, 2023, these shares were reported based on the beneficial ownership of each of the two separate retirement accounts, without reporting a CIK or CCC number for Mr. Shiff.
- [F2]The shares listed in Table I, Row 2, Column 3 are beneficially owned by Aleta Shiff, an individual through two retirement accounts. On the original Form 3 filed September 1, 2023, these shares were reported based on the beneficial ownership of each of the two separate retirement accounts, without reporting a CIK or CCC number for Ms. Shiff.